Critical analysis explores how goodwill influences asset value in the pharmaceutical sector, suggesting implications for investment and strategy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Pattnaik et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: